Oncolytics Biotech
ONCY
#9071
Rank
HK$0.95 B
Marketcap
HK$8.84
Share price
6.60%
Change (1 day)
60.16%
Change (1 year)

Oncolytics Biotech (ONCY) - Total debt

Total debt on the balance sheet as of September 2025 : HK$4.69 Million

According to Oncolytics Biotech 's latest financial reports the company's total debt is HK$4.69 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Oncolytics Biotech - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$5.75 M131.11%
2023-12-31HK$2.49 M15.97%
2022-12-31HK$2.14 M-46.41%
2021-12-31HK$4 M63.95%
2020-12-31HK$2.44 M-19.03%
2019-12-31HK$3.01 M
2018-12-31N/A
2006-12-31HK$1 M0.31%
2005-12-31HK$0.99 M2.93%
2004-12-31HK$0.97 M8.28%
2003-12-31HK$0.89 M21.02%
2002-12-31HK$0.74 M0.88%
2001-12-31HK$0.73 M-5.98%
2000-12-31HK$0.78 M-3.35%
1999-12-31HK$0.8 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eli Lilly
LLY
HK$332.49 B 7,087,206.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$368.76 B 7,860,251.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
HK$0.39 B 8,274.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
HK$13.19 M 181.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$133.72 B 2,850,296.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
HK$0.30 B 6,349.83%๐Ÿ‡บ๐Ÿ‡ธ USA